MedTrace Logo

Cancer in the Small Developing Island States of the Eastern Caribbean

NCT07695116 · Status: ENROLLING_BY_INVITATION · Type: OBSERVATIONAL · Enrollment: 900

Last updated 2026-07-10

No results posted yet for this study

Summary

Caribbean studies examining overseas cancer care were lacking patient-level data. Investigators will collect data from patients by establishing a cohort of survivors across six small island developing states (SIDS) (Antigua, Dominica, Grenada, Saint Kitts, Saint Lucia and Saint Vincent). This proposal is novel for the Caribbean, and it is the first step in identifying the critical performance gaps and leverage points in the process of overseas referral for cancer care. Investigators will compare for the first time, the characteristics and experiences of Caribbean cancer survivors in SIDS who seek care overseas to those who received care on-island.

My overarching goal is to investigate the effects of overseas travel for care on patient-centered outcomes in Caribbean SIDS, and to build a research resource to study cancer survival, as I develop my career as an independent mixed-method investigator.

Our primary aims are to (P1): Map patterns of overseas travel for cancer care among cancer survivors of six member states of the OECS and (P2): Explore the lived experience of cancer survivors and caregivers and how overseas travel for care affects their social support systems.

Investigators anticipate that (H1) a substantial proportion of cancer survivors travel outside of their resident country for cancer. We expect certain destinations to be more frequented among cancer survivors by individual characteristics (cancer site, stage and country of residence). We also expect that (H2) overseas care may be associated with both challenges and adaptations in social support systems, as explored qualitatively through survivor and caregiver accounts.

Conditions

Interventions

OTHER

Overeseas travel for care

Cancer survivors who travel overseas travel for care (observation)

Sponsors & Collaborators

  • Vaughan A. Lewis Institute for Research and Innovation

    lead OTHER

Principal Investigators

  • Aviane Auguste, PhD · Vaughan A. Lewis Institute for Research and Innovation

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2024-09-16
Primary Completion
2028-08-15
Completion
2028-08-15

Countries

  • Antigua and Barbuda
  • Dominica
  • Grenada
  • Saint Kitts and Nevis
  • Saint Lucia
  • Saint Vincent and the Grenadines

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT07695116 on ClinicalTrials.gov